Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

MCKENZIE MEMORIAL HOSPITAL

NPI: 1497750608 · SANDUSKY, MI 48471 · Medicare Defined Swing Bed Hospital Unit · NPI assigned 06/15/2005

$6.09M
Total Medicaid Paid
119,565
Total Claims
95,540
Beneficiaries
88
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialRUEDISUELI, AMY (V.P. FINANCE)
NPI Enumeration Date06/15/2005

Related Entities

Other providers sharing the same authorized official: RUEDISUELI, AMY

ProviderCityStateTotal Paid
MCKENZIE MEMORIAL HOSPITAL SANDUSKY MI $2.69M
MCKENZIE MEMORIAL HOSPITAL SANDUSKY MI $940K
MCKENZIE MEMORIAL HOSPITAL SANDUSKY MI $135K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 16,295 $645K
2019 18,721 $710K
2020 14,271 $736K
2021 17,305 $885K
2022 19,102 $1.07M
2023 19,015 $1.03M
2024 14,856 $1.01M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99284 Emergency department visit for the evaluation and management, high severity 7,909 5,350 $1.27M
99283 Emergency department visit for the evaluation and management, moderate severity 13,434 8,397 $1.19M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 3,548 2,394 $999K
A0425 Ground mileage, per statute mile 3,265 2,570 $488K
A0427 Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) 1,902 1,583 $436K
99282 Emergency department visit for the evaluation and management, low to moderate severity 4,015 2,734 $236K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1,931 1,771 $229K
A0429 Ambulance service, basic life support, emergency transport (bls-emergency) 723 622 $130K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 1,217 1,156 $118K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1,106 784 $111K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 3,967 1,154 $91K
96361 Intravenous infusion, hydration; each additional hour 1,950 1,683 $81K
70450 Computed tomography, head or brain; without contrast material 830 793 $79K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 3,887 1,129 $77K
71045 Radiologic examination, chest; single view 1,492 1,388 $65K
96375 Therapeutic injection; each additional sequential IV push 1,574 1,386 $58K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 1,561 1,522 $55K
71046 Radiologic examination, chest; 2 views 1,269 1,195 $54K
74177 Computed tomography, abdomen and pelvis; with contrast material 249 242 $49K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 576 559 $32K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 3,231 3,058 $31K
77067 Screening mammography, bilateral, including computer-aided detection 419 418 $26K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 204 199 $21K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 1,632 1,374 $20K
36415 Collection of venous blood by venipuncture 10,131 8,813 $18K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 177 168 $17K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 1,107 1,093 $15K
97161 216 215 $15K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 885 861 $11K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only 1,874 1,746 $9K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 2,415 2,227 $8K
77063 Screening digital breast tomosynthesis, bilateral 386 386 $6K
74176 Computed tomography, abdomen and pelvis; without contrast material 52 50 $6K
80053 Comprehensive metabolic panel 5,149 4,626 $6K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 423 416 $5K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring 12 12 $4K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 6,148 5,380 $4K
87631 114 111 $4K
84443 Thyroid stimulating hormone (TSH) 392 387 $2K
73630 120 120 $2K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 80 77 $2K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 60 58 $2K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1,711 1,472 $1K
97035 188 63 $1K
73610 57 54 $979.29
73130 85 80 $909.75
73030 27 26 $803.54
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1,048 900 $803.43
80061 Lipid panel 76 76 $596.83
80048 Basic metabolic panel (calcium, ionized) 1,407 1,259 $547.78
84484 1,766 1,535 $373.31
0100U 41 39 $316.00
80305 640 579 $312.01
99281 Emergency department visit for the evaluation and management, self-limited or minor 18 12 $289.07
85610 1,462 1,328 $280.24
80306 610 556 $270.40
83735 1,817 1,623 $226.91
83690 899 839 $133.32
81001 1,356 1,293 $82.17
82550 717 617 $80.10
82553 538 464 $72.10
83605 924 830 $71.63
85027 124 103 $58.09
81003 2,147 2,030 $51.82
83880 197 185 $51.47
84100 1,130 1,041 $50.84
85730 1,317 1,228 $50.11
81025 1,643 1,533 $49.76
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 163 130 $49.08
82150 211 205 $45.71
87086 Culture, bacterial; quantitative colony count, urine 24 24 $41.93
82962 146 111 $2.47
J1885 Injection, ketorolac tromethamine, per 15 mg 1,841 1,719 $1.22
J2405 Injection, ondansetron hydrochloride, per 1 mg 1,171 1,086 $0.36
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 1,141 1,090 $0.00
J7120 Ringers lactate infusion, up to 1000 cc 507 490 $0.00
J2270 Injection, morphine sulfate, up to 10 mg 28 25 $0.00
80179 151 126 $0.00
80143 153 128 $0.00
84145 44 41 $0.00
J2704 Injection, propofol, 10 mg 242 237 $0.00
87040 44 39 $0.00
96376 12 12 $0.00
J3010 Injection, fentanyl citrate, 0.1 mg 13 13 $0.00
J1100 Injection, dexamethasone sodium phosphate, 1 mg 42 42 $0.00
85008 16 13 $0.00
85379 26 24 $0.00
J0131 Injection, acetaminophen, not otherwise specified,10 mg 13 13 $0.00